Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

Oral GLP-1 Medicine Offers Once-Daily Option for Weight Management and Type 2 Diabetes

EMA news on a once-daily oral GLP-1 tablet that offers an alternative to existing oral and injectable therapies for weight management and type 2 diabetes.

By Dr. A. Nikhil Krishnan, MBBS · Oct 19, 2026 · 4 min read

Endocrinology·NEJM

Setmelanotide Phase 3 Trial Targets Acquired Hypothalamic Obesity

A phase 3 trial evaluates setmelanotide in acquired hypothalamic obesity after phase 2 weight-loss signals, using daily subcutaneous…

Oct 19, 2026

Endocrinology·PLOS ONE

Sleep Quality and Muscle Loss Track Adiposity Gains in Korean Adults

Two-year cohort data link worsening sleep and lower activity to adiposity gain, while body fat and skeletal muscle…

Oct 19, 2026

Endocrinology·MedCity

OMass raises $310M to advance CAH drug OMS1620

OMass secured $310 million to advance OMS1620 for congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome through Phase 2…

Oct 19, 2026

Endocrinology·Lan Resp

Mexico diabetes subclassification framework aims to refine type 2 diabetes care

A Mexico-based framework adapts data-driven type 2 diabetes subgroups to settings where beta-cell and insulin resistance testing is…

Oct 19, 2026

Endocrinology·Lan D&E

Endocrine Osteoporosis Care Moves Beyond T-Score in Adults

A narrative review outlines how fracture history, falls, frailty, FRAX, and drug safety should shape adult endocrine osteoporosis…

Oct 19, 2026

Endocrinology·Lan D&E

Ultra-Processed Food Exposure Linked to Obesity, Diabetes, and Mortality

A narrative review examines evidence linking ultra-processed food exposure to obesity, diabetes, cardiovascular disease, cancer, depression, and mortality.

Oct 19, 2026

Endocrinology·Nature